Actavis Completes Forest Laboratories Acquisition LEARN MORE>
Actavis Completes Forest Laboratories Acquisition

Specialty R&D

Strengthening Our Premier Brands Pipeline

Allergan’s brands R&D team drives an industry-leading pipeline of product opportunities focused on ensuring sustainable growth in key therapeutic categories including Dermatology and Aesthetics; Eye Care; CNS; Women’s Health and Urology; Anti-infectives and Gastroenterology.
The pipeline features more than 20 innovative products in near- or mid-term development, including Bimatoprost SR, Cariprazine, Esmya, Aczone X and Darpin AMD.
Our R&D strategy is focused on continuing to build this pipeline through organic development as well as partnerships, collaborations and in-licensing.